MTD · Mettler Toledo International Inc · Insider Trading
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 4 and 5. Form 3 supplies initial ownership rather than a trade; Form 4 must be filed within two business days of the trade.
Insider Sentiment Score
Peer-relative 0–100 rank of how aggressively insiders accumulated over the trailing 90 days. See the full ranking.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-11-12 | Wong Ann Ping Richard |
Head of Asia & Pacific |
Award↑
Filing footnotes — Common Stock, par value $0.01 per share (Direct)
Represents the number of shares earned in respect of the three-year performance period that was certified on November 12, 2026, which shares will be delivered upon vesting in January 2027. |
Common Stock, par value $0.01 per share
|
64 |
| 2026-11-12 | Keller Gerry |
Head of Process Analytics |
Award↑
Filing footnotes — Common Stock, par value $0.01 per share (Direct)
Represents the number of shares earned in respect of the three-year performance period that was certified on November 12, 2026, which shares will be delivered upon vesting in January 2027. |
Common Stock, par value $0.01 per share
|
62 |
| 2026-11-12 | Vadala Shawn |
Chief Financial Officer |
Award↑
Filing footnotes — Common Stock, par value $0.01 per share (Direct)
Represents the number of shares earned in respect of the three-year performance period that was certified on November 12, 2026, which shares will be delivered upon vesting in January 2027. |
Common Stock, par value $0.01 per share
|
176 |
| 2026-11-12 | Kaltenbach Patrick |
EVP & Pres Life Sciences |
Award↑
Filing footnotes — Common Stock, par value $0.01 per share (Direct)
Represents the number of shares earned in respect of the three-year performance period that was certified on November 12, 2026, which shares will be delivered upon vesting in January 2027. |
Common Stock, par value $0.01 per share
|
534 |
| 2026-11-12 | Wittorf Oliver |
Head of PI, Retail, and GSC |
Award↑
Filing footnotes — Common Stock, par value $0.01 per share (Direct)
Represents the number of shares earned in respect of the three-year performance period that was certified on November 12, 2026, which shares will be delivered upon vesting in January 2027. |
Common Stock, par value $0.01 per share
|
51 |
| 2026-11-10 | Doat-Le Bigot Domitille |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The options vest annually in two equal installments beginning on the first anniversary of the date of grant. |
Stock Option (right to buy)
|
130 |
| 2026-11-10 | Perversi Pablo |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The options vest annually in two equal installments beginning on the first anniversary of the date of grant. |
Stock Option (right to buy)
|
130 |
| 2026-11-10 | SALICE THOMAS P |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The options vest annually in two equal installments beginning on the first anniversary of the date of grant. |
Stock Option (right to buy)
|
130 |
| 2026-11-10 | SHUMAN-FABBRI NATALIA |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The options vest annually in two equal installments beginning on the first anniversary of the date of grant. |
Stock Option (right to buy)
|
130 |
| 2026-11-10 | Wittorf Oliver |
Head of PI, Retail, and GSC |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The options vest annually in five equal installments beginning on the first anniversary of the date of grant. |
Stock Option (right to buy)
|
130 |
| 2026-11-10 | Doat-Le Bigot Domitille |
Director |
Award↑
|
Common Stock, par value $0.01 per share
|
54 |
| 2026-11-10 | Kaltenbach Patrick |
EVP & Pres Life Sciences |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The options vest annually in five equal installments beginning on the first anniversary of the date of grant. |
Stock Option (right to buy)
|
1,180 |
| 2026-11-10 | FINNEY ELISHA W |
Director |
Award↑
|
Common Stock, par value $0.01 per share
|
54 |
| 2026-11-10 | Vadala Shawn |
Chief Financial Officer |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The options vest annually in five equal installments beginning on the first anniversary of the date of grant. |
Stock Option (right to buy)
|
425 |
| 2026-11-10 | Vadala Shawn |
Chief Financial Officer |
Award↑
|
Common Stock, par value $0.01 per share
|
179 |
| 2026-11-10 | Shepherd Brian A |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The options vest annually in two equal installments beginning on the first anniversary of the date of grant. |
Stock Option (right to buy)
|
130 |
| 2026-11-10 | Wong Ann Ping Richard |
Head of Asia & Pacific |
Award↑
|
Common Stock, par value $0.01 per share
|
58 |
| 2026-11-10 | DIGGELMANN ROLAND D |
Director |
Award↑
|
Common Stock, par value $0.01 per share
|
138 |
| 2026-11-10 | TOKICH MICHAEL J |
Director |
Award↑
|
Common Stock, par value $0.01 per share
|
54 |
| 2026-11-10 | Kaltenbach Patrick |
EVP & Pres Life Sciences |
Award↑
|
Common Stock, par value $0.01 per share
|
496 |
| 2026-11-10 | Graham-Bryce Susan |
Chief Human Resources Officer |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The options vest annually in five equal installments beginning on the first anniversary of the date of grant. |
Stock Option (right to buy)
|
100 |
| 2026-11-10 | Graham-Bryce Susan |
Chief Human Resources Officer |
Award↑
|
Common Stock, par value $0.01 per share
|
44 |
| 2026-11-10 | SALICE THOMAS P |
Director |
Award↑
|
Common Stock, par value $0.01 per share
|
77 |
| 2026-11-10 | SHUMAN-FABBRI NATALIA |
Director |
Award↑
|
Common Stock, par value $0.01 per share
|
54 |
| 2026-11-10 | Zhang Ingrid |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The options vest annually in two equal installments beginning on the first anniversary of the date of grant. |
Stock Option (right to buy)
|
130 |
| 2026-11-10 | TOKICH MICHAEL J |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The options vest annually in two equal installments beginning on the first anniversary of the date of grant. |
Stock Option (right to buy)
|
130 |
| 2026-11-10 | FINNEY ELISHA W |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The options vest annually in two equal installments beginning on the first anniversary of the date of grant. |
Stock Option (right to buy)
|
130 |
| 2026-11-10 | Wienand Wolfgang |
Director |
Award↑
|
Common Stock, par value $0.01 per share
|
54 |
| 2026-11-10 | DIGGELMANN ROLAND D |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The options vest annually in two equal installments beginning on the first anniversary of the date of grant. |
Stock Option (right to buy)
|
328 |
| 2026-11-10 | Keller Gerry |
Head of Process Analytics |
Award↑
|
Common Stock, par value $0.01 per share
|
58 |
| 2026-11-10 | Keller Gerry |
Head of Process Analytics |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The options vest annually in five equal installments beginning on the first anniversary of the date of grant. |
Stock Option (right to buy)
|
135 |
| 2026-11-10 | Perversi Pablo |
Director |
Award↑
|
Common Stock, par value $0.01 per share
|
54 |
| 2026-11-10 | Zhang Ingrid |
Director |
Award↑
|
Common Stock, par value $0.01 per share
|
54 |
| 2026-11-10 | Shepherd Brian A |
Director |
Award↑
|
Common Stock, par value $0.01 per share
|
54 |
| 2026-11-10 | Wong Ann Ping Richard |
Head of Asia & Pacific |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The options vest annually in five equal installments beginning on the first anniversary of the date of grant. |
Stock Option (right to buy)
|
135 |
| 2026-11-10 | Wienand Wolfgang |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The options vest annually in two equal installments beginning on the first anniversary of the date of grant. |
Stock Option (right to buy)
|
130 |
| 2026-11-10 | Wittorf Oliver |
Head of PI, Retail, and GSC |
Award↑
|
Common Stock, par value $0.01 per share
|
54 |
| 2026-11-09 | Keller Gerry |
Head of Process Analytics |
Convert↑
|
Common Stock, par value $0.01 per share
|
200 |
| 2026-11-09 | Keller Gerry |
Head of Process Analytics |
Sell↓
|
Common Stock, par value $0.01 per share
|
25 |
| 2026-11-09 | Keller Gerry |
Head of Process Analytics |
Convert↓
Filing footnotes — Stock Option (right to buy) (Direct)
The options vested annually in five equal installments beginning on the first anniversary of the date of grant. |
Stock Option (right to buy)
|
235 |
| 2026-11-09 | Keller Gerry |
Head of Process Analytics |
Sell↓
|
Common Stock, par value $0.01 per share
|
410 |
| 2026-11-09 | Keller Gerry |
Head of Process Analytics |
Convert↑
|
Common Stock, par value $0.01 per share
|
235 |
| 2026-11-09 | Keller Gerry |
Head of Process Analytics |
Convert↓
Filing footnotes — Stock Option (right to buy) (Direct)
The options vested annually in five equal installments beginning on the first anniversary of the date of grant. |
Stock Option (right to buy)
|
200 |
| 2026-08-28 | SHUMAN-FABBRI NATALIA |
Director |
Award↑
|
Common Stock, par value $0.01 per share
|
16 |
| 2026-08-27 | Kaltenbach Patrick |
EVP & Pres Life Sciences |
Sell↓
|
Common Stock, par value $0.01 per share
|
942 |
| 2026-08-27 | Kaltenbach Patrick |
EVP & Pres Life Sciences |
Convert↓
Filing footnotes — Stock Option (right to buy) (Direct)
The options vest annually in five equal installments beginning on the first anniversary of the date of grant. |
Stock Option (right to buy)
|
942 |
| 2026-08-27 | Kaltenbach Patrick |
EVP & Pres Life Sciences |
Convert↑
|
Common Stock, par value $0.01 per share
|
942 |
| 2026-08-05 | SALICE THOMAS P |
Director |
Convert↓
Filing footnotes — Stock Option (right to buy) (Direct)
The options vested annually in two equal installments beginning on the first anniversary of the date of grant. |
Stock Option (right to buy)
|
417 |
| 2026-08-05 | SALICE THOMAS P |
Director |
Sell↓
|
Common Stock, par value $0.01 per share
|
417 |
| 2026-08-05 | SALICE THOMAS P |
Director |
Convert↑
|
Common Stock, par value $0.01 per share
|
417 |